Payal Desai: Highlights from the NASCC 2026 Sickle Cell Workshop
Payal Desai, Associate Professor at Wake Forest University School of Medicine, Director, Sickle Cell Enterprise at Atrium Health, shared a Julie Kanter-Washko’s post on LinkedIn:
“The highlight of this group is always community.
How do you grow access for sickle cell?
Supporting centers and help build one place at a time. It’s an essential part of conquer SCD NASCC 2026 with the co-directors – Cece Calhoun Sheinei Alan, Sophie Lanzkron, Julie Kanter-Washko and so many more faculty Ted Wun.”
Julie Kanter-Washko, Professor/Associate Professor at University of Alabama at Birmingham, shared a post on LinkedIn:
“It was an amazing weekend National Alliance of Sickle Cell Centers (NASCC) SCD workshop.
A phenomenal group of early sickle cell center was the perfect start to a weekend of community.
We also had fantastic faculty to support the engagement and passion for improving outcomes for Sickle cell disease.
I cannot wait for tomorrow to kick off NASCC 2026”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?